Assessment of Early Healing Period of Dental Implants
Launched by KUTAHYA HEALTH SCIENCES UNIVERSITY · Aug 12, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Over the age of 18
- • Systemically healthy
- • Need for implant treatment in unilaterally edentulous posterior mandible
- • Sufficient interocclusal space for implant and restoration placement
- • At least four months passed since tooth extraction
- • Alveolar bone height adequate for implant placement, with a minimum width of 6 mm, and without risking anatomical structures
- • Plaque and bleeding scores of less than 15% in the entire mouth
- • Presence of opposing teeth in occlusion
- • Written informed consent obtained, including permission for the use of data for research purposes
- Exclusion Criteria:
- • Poor oral hygiene
- • Uncontrolled periodontal disease
- • Pregnancy or lactation at any stage of the study
- • Uncontrolled diabetes
- • Patients with suppressed immune systems
- • History of radiotherapy to the head and neck region
- • Diseases or medications affecting bone metabolism
- • Smoking more than 10 cigarettes per day
- • Bone augmentation performed before or concurrently with the implant
- • Failure to achieve primary stability with the implant
About Kutahya Health Sciences University
Kutahya Health Sciences University is a premier academic institution dedicated to advancing healthcare through innovative research and clinical trials. Committed to fostering excellence in medical education and patient care, the university collaborates with leading researchers and healthcare professionals to conduct cutting-edge studies aimed at improving health outcomes. With a focus on translating scientific discoveries into practical applications, Kutahya Health Sciences University plays a vital role in shaping the future of healthcare through rigorous clinical research and interdisciplinary collaboration.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kutahya, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported